Document is current
Any future updates will be listed below
-
Authors
Bos, Lieuwe Durk Jacobus
de Grooth, Harm Jan
Tuinman, Pieter Roel
- License Information
-
More Information
Article History
First Online: 21 March 2023
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Bos reports grants from (1) Dutch lung foundation (Young investigator grant & Dirkje Postma Award), (2) from Dutch lung foundation and Health Holland (Public–Private Partnership grant) (3) from IMI COVID19 iniative, (4) from Amsterdam UMC fellowship, (5) from ZonMW COVID-19 Urgency grant and (6) from ERS Gold Metal for ARDS. Dr. Bos did consultancy and/or served on advisory board for Scailyte, Sobi, Exvastat, Santhera, Pfizer, Novartis and Astra Zeneca. None are relevant for the current publication.
